Aryl H-phosphonates 17: (N-aryl)phosphoramidates of pyrimidine nucleoside analogues and their synthesis, selected properties, and anti-HIV activity. 2011

Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznań, Poland.

New synthetic protocol for the preparation of nucleoside 5'-(N-aryl)phosphoramidate monoesters 4 was developed. It consisted of a condensation of the corresponding nucleoside 5'-H-phosphonates with aromatic- or heteroaromatic amines promoted by diphenyl phosphorochloridate, followed by oxidation of the produced H-phosphonamidates with iodine/water. 5'-(N-Aryl)phosphoramidate monoesters derived from 3'-azido-3'-deoxythymidine (AZT) or 2',3'-dideoxyuridine (ddU) nucleosides and various aromatic and heteroaromatic amines were evaluated as potential anti-HIV drugs. It was found that these compounds act most likely as pronucleotides and that some of them have therapeutic indices superior to those of the reference AZT.

UI MeSH Term Description Entries
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D057927 Hydrophobic and Hydrophilic Interactions The thermodynamic interaction between a substance and WATER. Hydrophilic Interactions,Hydrophilic and Hydrophobic Interactions,Hydrophilicity,Hydrophobic Interactions,Hydrophobicity,Hydrophilic Interaction,Hydrophilicities,Hydrophobic Interaction,Hydrophobicities,Interaction, Hydrophilic,Interaction, Hydrophobic,Interactions, Hydrophilic,Interactions, Hydrophobic
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
March 2006, Bioorganic & medicinal chemistry,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
May 2009, Bioorganic & medicinal chemistry,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
January 2001, Acta biochimica Polonica,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
December 2007, Bioorganic & medicinal chemistry letters,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
September 2017, Bioorganic & medicinal chemistry,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
July 1997, Journal of medicinal chemistry,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
January 2020, Bioorganic & medicinal chemistry letters,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
September 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
August 2013, Organic letters,
Joanna Romanowska, and Michał Sobkowski, and Agnieszka Szymańska-Michalak, and Krystian Kołodziej, and Aleksandra Dąbrowska, and Andrzej Lipniacki, and Andrzej Piasek, and Zofia M Pietrusiewicz, and Marek Figlerowicz, and Andrzej Guranowski, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski
March 2006, Tetrahedron,
Copied contents to your clipboard!